To further investigate the mechanism of CASR in the treatment of CHD, the combined results of the KEGG enrichment analysis in network pharmacology prediction and the expression analysis of PI3K/AKT/mTOR signaling pathway components was verified. This evidence concerns the gene MTOR and coronary artery disorder.